[SCHEDULE 13G/A] Tenaya Therapeutics, Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

SCHEDULE 13G/A

Rhea-AI Filing Summary

Analyzing...

07/16/2025 - 07:02 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Tenaya Therapeutics, Inc.

#6511 Ranked by Market Cap

N/A Ranked by Dividends

May 15, 2025

May 13, 2025

May 7, 2025

Apr 24, 2025

Mar 31, 2025

Market Cap 111.88M

Float 161.04M

Insiders Ownership 1.42%

Institutions Ownership 106.82%

Short Percent 18.17%

Industry Biotechnology

Sector Biological Products, (no Disgnostic Substances)

Website Link

Country United States

City SOUTH SAN FRANCISCO